GlassScriptPhysician profile
Edwin T Taylor
NPI 1912153784
$368.12
in general payments reported to CMS, 2019-2025
15 companies · $71.19 in 2025
The $71.19 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $74.37 · 2020: $13.56 · 2021: $15.84 · 2022: $58.32 · 2023: $79.45 · 2024: $55.39 · 2025: $71.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $206.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $206.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $45.68 | 2019 | |
| Dexcom, INC. | $43.55 | 2023-2024 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $40.61 | 2023-2025 | Ozempic, Wegovy |
| Vapotherm INC | $37.82 | 2019-2022 | |
| Lilly USA, LLC | $34.96 | 2023 | Mounjaro, Trulicity |
| Exact Sciences Corporation | $21.88 | 2025 | The Cologuard Plus Collection Kit |
| Nestle Healthcare Nutrition INC. | $21.57 | 2022 | |
| Phathom Pharmaceuticals, INC. | $21.06 | 2024 | Voquezna |
| Abbvie INC. | $15.84 | 2021 | |
| Medtronic, INC. | $15.43 | 2025 | Inceptiv |
| Paratek Pharmaceuticals, INC. | $14.84 | 2025 | Nuzyra |
| Pfizer INC. | $14.23 | 2019 | |
| Merck Sharp & Dohme LLC | $13.70 | 2024 | Gardasil 9, Capvaxive, Gardasil |
| Allergan, INC. | $13.56 | 2020 | |
| Sanofi Pasteur INC. | $13.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edwin Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.